Company Plans Extension Study for Phase 3 Trial of Amyotrophic Lateral Sclerosis Drug
According to a story from pm360online.com, the Orion Corporation, a pharmaceutical company based in Finland, has recently announced that it plans to continue its Phase 3 trial of levosimendan as…